Corporate Profile

Hyperfine, Inc. is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared point-of-care MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a low magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.
Hyperfine Swoop COB LBL

Stock Information

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming EventsUpcoming Events

Featured ReportsFeatured Reports

More information is coming soon.
View All

News Releases

10 Aug '22
GUILFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended June 30, 2022. Management will host a corresponding conference call today at 1:30 p.m....
29 Jun '22
Launches global search for long-term CEO with Scott Huennekens to serve as interim President & CEO Reaffirms 2022 Financial Guidance GUILFORD, Conn., June 29, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (“Hyperfine” or “the Company”), the groundbreaking medical device company that...